Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2003
12/18/2003US20030232766 Combinatorial libraries of monosaccharides
12/18/2003US20030232763 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
12/18/2003US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide
12/18/2003US20030232739 Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232326 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
12/18/2003US20030232090 Anhydrous antifungal gel comprising polyhydric alcohol(s), a gelling agent and an antifungal azole such as econazole; treating oral and vaginal fungal and bacterial infections
12/18/2003US20030232078 Formulation & dosage form for the controlled delivery of therapeutic agents
12/18/2003US20030232036 Alphavirus RNA replicon systems
12/18/2003US20030232022 P. gingivalis antigenic composition
12/18/2003US20030232008 Oxazolidinone photoaffinity probes
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2489050A1 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells
12/18/2003CA2488801A1 Ether substituted imidazopyridines
12/18/2003CA2488609A1 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488497A1 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003CA2488403A1 Pharmaceutical formulation
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488385A1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
12/18/2003CA2488360A1 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
12/18/2003CA2488347A1 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer
12/18/2003CA2488193A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003CA2488108A1 Liquid formulation of decitabine and use of the same
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2484514A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
12/18/2003CA2473321A1 Flavivirus vaccines
12/17/2003EP1371730A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1371373A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
12/17/2003EP1371370A1 Drugs containing reduced vitamin b2
12/17/2003EP1371367A1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370551A2 New compounds useful as antibacterial agents
12/17/2003EP1370550A1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370543A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
12/17/2003EP1370539A1 Hiv inhibiting n-aminoimidazole derivatives
12/17/2003EP1370513A1 Malic acid addition salts of terbinafine
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370298A1 Elongated and multiple spacers in activatible prodrugs
12/17/2003EP1370296A2 Catecholate beta-lactam conjugates, method for producing the same and the use thereof
12/17/2003EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders
12/17/2003EP1370290A2 Molecular antigen array
12/17/2003EP1370289A2 Method for producing a vaccine containing autologous antibodies
12/17/2003EP1370283A2 Prevention of recurrent viral disease
12/17/2003EP1370274A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases
12/17/2003EP1370271A2 A process for the manufacture of a herbal composition comprising a matrine
12/17/2003EP1370265A1 Hiv inhibiting pyrazinone derivatives
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1370251A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
12/17/2003EP1370249A1 Novel dendriticpolymers and their biomedical uses
12/17/2003EP1370247A2 Taste masked pharmaceutical compositions
12/17/2003EP1370143A2 An antimicrobial composition
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003EP1142900B1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP0956349B1 Synthetic hpv16 virus-like particles
12/17/2003EP0902781B1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide
12/17/2003EP0871625B1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
12/17/2003EP0527753B2 Purification and use of pertactin, a bordetella pertussis outer membrane protein
12/17/2003EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor
12/17/2003CN1462309A Codon-optimized papilloma virus sequences
12/17/2003CN1462275A Phosphonocephem compound
12/17/2003CN1462274A Triazolo-epothilones
12/17/2003CN1461753A H-type non virus carrier and medicinal compound containing same
12/17/2003CN1461651A Method for producing medicine for treating Aids
12/17/2003CN1461649A Medicine for treating herpes zoster
12/17/2003CN1461646A Traditional Chinese medicine for treating AIDS
12/17/2003CN1461643A Water solution of ÔÇ£PenxiluoweiÔÇØ, and its prepn. method
12/17/2003CN1461638A Combined antidrotic and antimicrobic composite
12/17/2003CN1131229C Salt of naphthyridine carboxylic acid derivative
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131067C Tinea pedis external used medicament
12/17/2003CN1131040C Application of double-stranded ribonucleic acid in preparing medicine for treating human coxsackie virus infection
12/17/2003CN1131039C Process for preparing kelamycin injection
12/17/2003CN1131034C Novel pharmaceutical composition
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/17/2003CN1131026C Valaciclovir tablets containing colloidal silicon dioxide
12/16/2003US6664398 Derivatives of erythromycin, their preparation process and their use as medicaments
12/16/2003US6664368 Inhibition of nuclear import by backbone cyclic peptide analogs
12/16/2003US6664292 Topically applying to the affected area in the nail a lower alcohol and a lower carboxylic acid to treat the bacterial or fungal infection
12/16/2003US6664276 Antiulcer agent
12/16/2003US6664268 Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2, 8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
12/16/2003US6664267 Reduced hygroscopicity; aqueous solubility; low propensity to cause phlebitis
12/16/2003US6664265 Imidazo(4,5-c)quinoline-4-amines; inducing cytokine biosynthesis; viral and neoplastic disease treatment
12/16/2003US6664264 Thioether substituted imidazoquinolines
1 ... 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 1798